Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Neuroendocrine Tumors 2Multiple Endocrine Neoplasia Type 1 2Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Thymus Neoplasms 1Pituitary Neoplasms 1Pheochromocytoma 1Parathyroid Diseases 1Paraganglioma 1Pancreatic Neoplasms 1Obesity 1Midgut Neuroendocrine Tumors 1High Grade Neuroendocrine Neoplasms 1Brain Neoplasms 1Atherosclerosis 1Adrenocortical Carcinoma 1

Interventions

cabozantinib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
High Grade Neuroendocrine Neoplasms × Blood Specimen Collection × Endocrine × Clear all
NCT04412629 2026-04-06

Cabozantinib in High Grade Neuroendocrine Neoplasms

Washington University School of Medicine

Phase 2 Active not recruiting
35 enrolled
Endocrine

High Grade Neuroendocrine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡